| P2093 | author name string | Andris Zeltins | |
| P2860 | cites work | Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha | Q67980541 |
| | The influence of antigen organization on B cell responsiveness | Q72628042 |
| | Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat protein | Q82036716 |
| | Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation | Q82639977 |
| | ViralZone: a knowledge resource to understand virus diversity | Q24608854 |
| | A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection | Q24631774 |
| | Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16 | Q27625236 |
| | The capsid of the small RNA phage PRR1 is stabilized by metal ions | Q27652107 |
| | The structure of bacteriophage phiCb5 reveals a role of the RNA genome and metal ions in particle stability and assembly | Q27656265 |
| | Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography | Q27666147 |
| | Construction and crystal structure of recombinant STNV capsids | Q27671705 |
| | Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus | Q28473294 |
| | Low temperature-dependent salmonid alphavirus glycoprotein processing and recombinant virus-like particle formation | Q28744320 |
| | Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein | Q30195835 |
| | Metagenomics and future perspectives in virus discovery. | Q30224693 |
| | Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins | Q30303887 |
| | Viral vectors for the expression of proteins in plants | Q30319869 |
| | Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A. | Q30319933 |
| | Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. | Q30351356 |
| | Plant-made vaccines for humans and animals. | Q30386732 |
| | Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice | Q30833219 |
| | Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications | Q33233438 |
| | Exploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expression | Q33283524 |
| | Assembly of recombinant coat protein of sugarcane streak mosaic virus into potyvirus-like particles | Q33393783 |
| | Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium | Q33496351 |
| | Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli | Q33636884 |
| | H1N1 Influenza Virus-Like Particles: Physical Degradation Pathways and Identification of Stabilizers | Q33644744 |
| | Cell-free protein synthesis: applications come of age. | Q33684275 |
| | Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry | Q33707408 |
| | From envelopes to atoms: The remarkable progress of biological electron microscopy | Q33758048 |
| | Expression, purification and characterization of enterovirus-71 virus-like particles | Q33788579 |
| | On-virus construction of polyvalent glycan ligands for cell-surface receptors | Q33792591 |
| | Vaccine potential of Nipah virus-like particles | Q33873756 |
| | Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants | Q42024081 |
| | Production of rotavirus-like particles in Spodoptera frugiperda larvae | Q42031671 |
| | Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses | Q42068520 |
| | Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae | Q42686115 |
| | Low pH-triggered model drug molecule release from virus-like particles | Q42828454 |
| | Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs | Q44317220 |
| | Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose | Q44413898 |
| | Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris | Q44606803 |
| | Adenovirus dodecahedron, a new vector for human gene transfer | Q45075858 |
| | Production and purification of SV40 major capsid protein (VP1) in Escherichia coli strains deficient for the GroELS chaperone machine. | Q45141835 |
| | Degenerate RNA packaging signals in the genome of Satellite Tobacco Necrosis Virus: implications for the assembly of a T=1 capsid | Q45296024 |
| | Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41. | Q45357217 |
| | Virus scaffolds as enzyme nano-carriers | Q45357838 |
| | Human parvovirus B19 virus-like particles: In vitro assembly and stability | Q45360874 |
| | Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches | Q45361083 |
| | Maize rayado fino virus virus-like particles expressed in tobacco plants: A new platform for cysteine selective bioconjugation peptide display | Q45362861 |
| | A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. | Q45365899 |
| | Efficient disulfide bond formation in virus-like particles | Q45366899 |
| | A highly sensitive and selective diagnostic assay based on virus nanoparticles | Q45385465 |
| | Expression and self-assembly of virus-like particles of infectious hypodermal and hematopoietic necrosis virus in Escherichia coli | Q45386263 |
| | Generation of menangle virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae | Q45402428 |
| | A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis | Q45403808 |
| | Expression and self-assembly of cowpea chlorotic mottle virus-like particles in Pseudomonas fluorescens | Q45409976 |
| | Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature | Q45417015 |
| | Assembly of bacteriophage Qbeta virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris | Q45420936 |
| | Production in Saccharomycescerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs | Q45484341 |
| | Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects | Q45698211 |
| | Isoelectric point determination of norovirus virus-like particles by capillary isoelectric focusing with whole column imaging detection | Q45701919 |
| | Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection | Q45711213 |
| | Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. | Q45729043 |
| | A molecular switch in the capsid protein controls the particle polymorphism in an icosahedral virus | Q45733476 |
| | Mutilation of RNA phage Qbeta virus-like particles: from icosahedrons to rods | Q45740242 |
| | Virus-like particles assemble in plants and bacteria expressing the coat protein gene of Indian peanut clump virus | Q45745026 |
| | Assembly of physalis mottle virus capsid protein in Escherichia coli and the role of amino and carboxy termini in the formation of the icosahedral particles | Q45760220 |
| | In vitro assembly of cowpea chlorotic mottle virus from coat protein expressed in Escherichia coli and in vitro-transcribed viral cDNA. | Q45783663 |
| | Synthesis and assembly of hepatitis B virus surface antigen particles in yeast | Q45793098 |
| | Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells | Q45849958 |
| | Biochemical and structural characterization of RHDV capsid protein variants produced in Pichia pastoris: advantages for immunization strategies and vaccine implementation. | Q47321894 |
| | Size and mechanical stability of norovirus capsids depend on pH: a nanoindentation study | Q47425917 |
| | High-level expression of soluble viral structural protein in Escherichia coli. | Q47936021 |
| | Controlled encapsulation of multiple proteins in virus capsids. | Q50575248 |
| | Maize rayado fino virus capsid proteins assemble into virus-like particles in Escherichia coli. | Q54395392 |
| | Assembly of mixed rod-like and spherical particles from group I and II RNA bacteriophage coat proteins. | Q54401681 |
| | DNA-templated CMV viral capsidproteins assemble into nanotubes | Q56833521 |
| | Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris | Q58005152 |
| | Catalytic capsids: the art of confinement | Q58490549 |
| | Electron microscopy of hepatitis B core antigen synthesized in E. coli | Q59098200 |
| | Virus-like particles in vaccine development. | Q37798008 |
| | Self-assembling viral mimetics: one long journey with short steps | Q37821835 |
| | Current strategies for subunit and genetic viral veterinary vaccine development. | Q37840709 |
| | Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances | Q37904359 |
| | Large-scale production and purification of VLP-based vaccines | Q37904378 |
| | Plant-derived antigens as mucosal vaccines | Q37910821 |
| | Therapeutic vaccines for chronic diseases: successes and technical challenges | Q37926764 |
| | Applications of plant viruses in bionanotechnology | Q37950913 |
| | Virus-like particles: potential veterinary vaccine immunogens | Q37958442 |
| | Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks | Q37980587 |
| | Assembly of hybrid bacteriophage Qbeta virus-like particles | Q38349472 |
| | Folding properties of the hepatitis B core as a carrier protein for vaccination research | Q39101348 |
| | SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure | Q39118758 |
| | Analysis of the size of DNA packaged by the human JC virus-like particle | Q39371549 |
| | Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins | Q39603298 |
| | The incorporation of the A2 protein to produce novel Qβ virus-like particles using cell-free protein synthesis. | Q39681830 |
| | Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design | Q39864273 |
| | Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids | Q39875441 |
| | Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples | Q39920223 |
| | Use of recombinant baculoviruses in synthesis of morphologically distinct viruslike particles of flock house virus, a nodavirus. | Q40044884 |
| | Structural requirements of astrovirus virus-like particles assembled in insect cells | Q40273999 |
| | Biopharmaceutical benchmarks 2006. | Q40307417 |
| | Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate | Q40352155 |
| | Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice | Q40359887 |
| | Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles | Q40445144 |
| | Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function | Q40522838 |
| | Cell-type specific targeting and gene expression using a variant of polyoma VP1 virus-like particles | Q40658568 |
| | Analysis of the capsid processing strategy of Thosea asigna virus using baculovirus expression of virus-like particles | Q40836172 |
| | Co-expression of the capsid proteins of Cowpea mosaic virus in insect cells leads to the formation of virus-like particles | Q40841202 |
| | Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles | Q41039790 |
| | Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322 | Q41053074 |
| | Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle | Q41079116 |
| | Neutralizing antiviral B cell responses | Q41464284 |
| | Symmetry, flexibility and permeability in the structure of yeast retrotransposon virus-like particles | Q41519582 |
| | Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy | Q41635323 |
| | Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae | Q42010724 |
| | Production of recombinant protein therapeutics in cultivated mammalian cells | Q33982884 |
| | A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice | Q34039347 |
| | Preparation of extracts from prokaryotes | Q34149529 |
| | Construction of a baculovirus-silkworm multigene expression system and its application on producing virus-like particles | Q34189511 |
| | A simple and general method for determining the protein and nucleic acid content of viruses by UV absorbance | Q34241011 |
| | Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity | Q34256293 |
| | Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever | Q34322342 |
| | Ebola virus-like particles protect from lethal Ebola virus infection | Q34792924 |
| | Progress and problems with the use of viral vectors for gene therapy | Q35120176 |
| | Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen | Q35123908 |
| | Protein delivery using engineered virus-like particles | Q35345000 |
| | Using polymer conformation to control architecture in semiconducting polymer/viral capsid assemblies | Q35549599 |
| | Therapeutic vaccination for chronic diseases: a new class of drugs in sight | Q35604228 |
| | Prevention of cervical cancer through papillomavirus vaccination | Q35620080 |
| | Host RNAs, including transposons, are encapsidated by a eukaryotic single-stranded RNA virus | Q35751107 |
| | Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations | Q35754185 |
| | Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli | Q35761619 |
| | Expression and self-assembly of empty virus-like particles of hepatitis E virus | Q35894748 |
| | Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells | Q35896548 |
| | Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae | Q36098951 |
| | Towards the preparative and large-scale precision manufacture of virus-like particles | Q36220766 |
| | Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses | Q36650409 |
| | RNA-controlled polymorphism in the in vivo assembly of 180-subunit and 120-subunit virions from a single capsid protein | Q36698575 |
| | Enzymatic lysis of microbial cells. | Q36803860 |
| | Assembly of virus-like particles in insect cells infected with a baculovirus containing a modified coat protein gene of potato leafroll luteovirus | Q36813715 |
| | Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli. | Q37329062 |
| | Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system | Q37365388 |
| | Chemical modification of viruses and virus-like particles | Q37386904 |
| | Modern uses of electron microscopy for detection of viruses | Q37409983 |
| | Biological gene delivery vehicles: beyond viral vectors | Q37412239 |
| | Peptide-mediated DNA condensation for non-viral gene therapy. | Q37430562 |
| | Plant-based oral vaccines: results of human trials | Q37463784 |
| | Virus hybrids as nanomaterials for biotechnology | Q37778161 |
| P433 | issue | 1 | |
| P921 | main subject | virus | Q808 |
| P304 | page(s) | 92-107 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Molecular Biotechnology | Q15761195 |
| P1476 | title | Construction and characterization of virus-like particles: a review | |
| P478 | volume | 53 | |